New drug duo aims to outsmart resistant lung cancer
NCT ID NCT04606771
Summary
This study is testing whether adding a new drug called savolitinib to a patient's current lung cancer medication (osimertinib) can help control the cancer after it has started growing again. It will involve about 30 adults with a specific type of advanced lung cancer. Patients will be randomly assigned to receive either the two-drug combination or savolitinib with a placebo pill, to see which approach works better.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Duarte, California, 91010, United States
-
Research Site
Sacramento, California, 95817, United States
-
Research Site
Ciudad de Buenos Aires, C1120AAT, Argentina
-
Research Site
Delhi, 110085, India
-
Research Site
Mumbai, 400053, India
-
Research Site
Taichung, 402, Taiwan
-
Research Site
Taipei, 100, Taiwan
-
Research Site
Taipei, 11217, Taiwan
-
Research Site
Taipei, 235, Taiwan
-
Research Site
Taoyuan, 333, Taiwan
-
Research Site
Bangkok, 10210, Thailand
-
Research Site
Bangkok, 10300, Thailand
-
Research Site
Bangkok, 10330, Thailand
-
Research Site
Bangkok, 10400, Thailand
-
Research Site
Bangkok, 10700, Thailand
-
Research Site
Hat Yai, 90110, Thailand
-
Research Site
Khon Kaen, 40002, Thailand
-
Research Site
Muang, 50200, Thailand
-
Research Site
Hanoi, 100000, Vietnam
-
Research Site
Hà Nội, 100000, Vietnam
-
Research Site
Ho Chi Minh City, 700000, Vietnam
Conditions
Explore the condition pages connected to this study.